The Valley Desk

NCT02707328 · Interventional trial

Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)

Overall registry status Terminated

Phase 1

Conditions Adenocarcinoma of the Pancreas, Pancreas Adenocarcinoma, Pancreas Cancer, Pancreatic Adenocarcinoma, Pancreatic Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov